Poltreg S.A.
PTG | WAR
Overview
Corporate Details
- ISIN(s):
- PLPLTRG00012 (+2 more)
- LEI:
- 259400XSAJTERJ42VZ86
- Country:
- Poland
- Address:
- GDAŃSK BOTANICZNA 20, 80-298 GDAŃSK
- Website:
- https://poltreg.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Poltreg S.A. is a biotechnology company based in Poland that focuses on developing innovative therapies for autoimmune diseases. The company specializes in using T-regulatory cells (TREGs) to develop a new generation of medicines aimed at treating autoimmune diseases , such as diabetes type 1 and multiple sclerosis. Poltreg S.A. is currently conducting various stages of research and development projects in these areas to offer medical solutions to those suffering from autoimmune diseases . The company's strong commitment to research and development is reinforced by its team of qualified scientists and researchers dedicated to developing new technologies and techniques to improve health outcomes.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-04 14:37 |
Legal Proceedings Report
Podanie pierwszemu pacjentowi terapii w ramach badania klinicznego fazy II w pr…
|
Polish | 2.8 KB | |
| 2025-07-31 08:50 |
Legal Proceedings Report
Otrzymanie od FDA protokołu z podsumowaniem spotkania pre-IND - Content (PL)
|
Polish | 2.0 KB | |
| 2025-07-29 14:05 |
Regulatory News Service
Otrzymanie Certyfikatu Dobrej Praktyki Wytwarzania od Głównego Inspektora Farma…
|
Polish | 1005 bytes | |
| 2025-06-23 15:30 |
Regulatory News Service
Warunkowe przyznanie europejskiego patentu dotyczącego metody ekspansji ex vivo…
|
Polish | 884 bytes | |
| 2025-06-13 15:56 |
Foreign Filer Report
Rejestracja spółki zależnej Immuthera w USA - Content (PL)
|
Polish | 784 bytes | |
| 2025-05-21 12:30 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Zgromadze…
|
Polish | 2.3 KB | |
| 2025-05-20 22:12 |
M&A Activity
Warunkowe przyznanie patentu przez Australijski Urząd Patentowy w projekcie ter…
|
Polish | 1.4 KB | |
| 2025-05-20 22:12 |
M&A Activity
Warunkowe przyznanie patentu przez Australijski Urząd Patentowy w projekcie ter…
|
Polish | 1.3 KB | |
| 2025-05-20 15:45 |
Remuneration Information
Sprawozdanie RN o wynagrodzeniach
|
Polish | 1.2 MB | |
| 2025-05-20 15:45 |
Post-Annual General Meeting Information
Podjęte Uchwały
|
Polish | 184.3 KB | |
| 2025-05-20 15:45 |
Post-Annual General Meeting Information
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie PolTREG S.A. w dniu 2…
|
Polish | 729 bytes | |
| 2025-05-19 23:25 |
Regulatory News Service
Warunkowe przyznanie patentu przez Japoński Urząd Patentowy w projekcie terapii…
|
Polish | 1.6 KB | |
| 2025-05-19 11:17 |
Board/Management Information
CV
|
Polish | 1.2 MB | |
| 2025-05-19 11:17 |
Board/Management Information
Zgłoszenie kandydata na Członka Rady Nadzorczej PolTREG S.A. - Content (PL)
|
Polish | 1.7 KB | |
| 2025-05-18 23:25 |
Regulatory News Service
Warunkowe przyznanie patentu przez Japoński Urząd Patentowy w projekcie terapii…
|
Polish | 1.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
BioPorto | Denmark | BIOPOR | |
|
BioSenic SA | Belgium | BIOS | |
|
Biosergen AB | Sweden | BIOSGN | |
|
BIOTECH | Spain | BST | |
|
Biotest AG | Germany | BIO3 | |
|
Bioton S.A. | Poland | BIO | |
|
Bioversys N | Switzerland | BIOV | |
|
Biovica International B | Sweden | BIOVIC | |
|
Bonus BioGroup Ltd. | Israel | BONS | |
|
BRAIN Biotech AG | Germany | BNN |